Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Real-Time Adherence Monitoring for HIV Antiretroviral Therapy

Bibliographic Data

ID15338342
AuthorsJessica E Haberer (0000-0001-5845-3190, Center for Global Health, corresponding author), Josh Kahane (Harvard Global Health Institute), Isaac Kigozi (Mbarara University of Science and Technology), Nneka Emenyonu (0000-0003-4376-7810, Mbarara University of Science and Technology), Peter W Hunt (0000-0002-4571-4870, University of California, San Francisco), Peter Hunt (0000-0002-7227-5623), Judith N Martins (0000-0002-9773-3256, University of California, San Francisco), Jeffrey Martin (0000-0001-5070-7432), David R Bangsberg (0000-0002-6352-8908, Center for Global Health)
Year2010
Volume14
Issue6
Pages1340-1346
Publication date2010-08-30
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueAIDS and Behavior (JOURNAL)
Journal identifiersISSN: 1090-7165 • E-ISSN: 1573-3254
PublisherSpringer Science+Business Media (PUBLISHER • DE)
DOI10.1007/s10461-010-9799-4
PMID20809380
PMCIDPMC2974938
OpenAlexW2109168061
LanguageEN
Citations received54
References cited23

Current adherence assessments typically detect missed doses long after they occur. Real-time, wireless monitoring strategies for antiretroviral therapy may provide novel opportunities to proactively prevent virologic rebound and treatment failure. Wisepill, a wireless pill container that transmits a cellular signal when opened, was pilot tested in ten Ugandan individuals for 6 months. Adherence levels measured by Wisepill, unannounced pill counts, and self-report were compared with each other, prior standard electronic monitoring, and HIV RNA. Wisepill data was initially limited by battery life and signal transmission interruptions. Following device improvements, continuous data was achieved with median (interquartile range) adherence levels of 93% (87-97%) by Wisepill, 100% (99-100%) by unannounced pill count, 100% (100-100%) by self-report, and 92% (79-98%) by prior standard electronic monitoring. Four individuals developed transient, low-level viremia. After overcoming technical challenges, real-time adherence monitoring is feasible for resource-limited settings and may detect suboptimal adherence prior to viral rebound

Antiretroviral therapy · Human immunodeficiency virus (HIV · Intensive care medicine · Interquartile range · Pill · Viral load · Viremia · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Emergency Medicine · Immunology · Internal Medicine · Pharmacology

  • Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa

    Open Access•Alexander J Lankowski, Mark J Siedner et al.•AIDS and Behavior•2014

  • Defining success with HIV pre-exposure prophylaxis

    Jessica E Haberer, David R Bangsberg et al.•AIDS•2015

  • Applying convergent parallel mixed methods design to investigate medication adherence among people living with HIV in resource-limited settings

    Open Access•Victor Luckyboy Dzramado, Emmanuel Oduro et al.•Frontiers in Public Health•2026

  • Qualitative Identification of Intervention Preferences to Support Men’s Engagement and Retention in TB Care in South Africa

    Open Access•Andrew Medina-Marino, Dana Bezuidenhout et al.•American Journal of Men s Health•2022

  • The Vuka family program

    Arvin Bhana, Claude Ann Mellins et al.•AIDS Care•2014

  • Experience with antiretroviral electronic adherence monitoring among young African American men who have sex with men living with HIV

    Mark S Dworkin, Palak Panchal et al.•AIDS Care•2020

  • Lessons learned from a mobile technology-based intervention informed by behavioral economics to improve ART adherence among youth in Uganda

    Sarah Maccarthy, Alexandra Mendoza-Graf et al.•AIDS Care•2020

  • Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV

    Jennifer A Pellowski, Seth C Kalichman et al.•AIDS Care•2016

  • Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States

    Rachelle Reid, Sannisha K Dale•AIDS Care•2022

  • Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda

    Open Access•Angella Musiimenta, Esther C Atukunda et al.•AIDS Care•2018

  • Interventions to enhance HIV medication adherence among individuals using substances

    Open Access•Chavez R Rodriguez, McKalaih E Legault et al.•AIDS Care•2026

  • The Relationship Between Harmful Alcohol Use and Antiretroviral Non-adherence in People Accessing HIV Treatment in Cape Town, South Africa

    Open Access•Alexandra L Rose, Jennifer M Belus et al.•AIDS and Behavior•2022

  • Addressing Syndemics and Self-care in Individuals with Uncontrolled HIV

    Open Access•Steven A Safren, Audrey Harkne et al.•AIDS and Behavior•2020

  • Retention in HIV Care Among HIV-Seropositive Pregnant and Postpartum Women in Uganda

    Open Access•Lora Sabin, Nafisa Halim et al.•AIDS and Behavior•2020

  • A Novel Breath Test to Directly Measure Use of Vaginal Gel and Condoms

    Open Access•Ariane Van Der Straten, Helen Cheng et al.•AIDS and Behavior•2013

  • True Durability

    Open Access•Debra Benator, Debra A Benator et al.•AIDS and Behavior•2014

  • Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events

    Open Access•Tanuja N Gengiah, Michele Upfold et al.•AIDS and Behavior•2014

  • Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots

    Open Access•Christopher M Ferraris, Paul D’Avanzo et al.•AIDS and Behavior•2023

  • Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or “How the ‘Broken Window’ Theory Pertains to ART Adherence”

    Open Access•Christopher J Gill, Christopher Gill et al.•AIDS and Behavior•2015

  • Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting

    Open Access•I Marion de Sumari-de Boer, Jossy Van Den Boogaard et al.•AIDS and Behavior•2015

  • Use of a Novel Technology to Track Adherence to Product Use in a Microbicide Trial of Short Duration (MTN-007)

    Open Access•Cheng-Shiun Leu, Cheng‐Shiun Leu et al.•AIDS and Behavior•2013

  • Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda

    Open Access•Angella Musiimenta, Jeffrey I Campbell et al.•AIDS and Behavior•2021

  • Gendered Racial Microaggressions, Self-silencing, Substance Use, and HIV Outcomes Among Black Women Living with HIV

    Open Access•Naysha N Shahid, Sannisha K Dale•AIDS and Behavior•2023

  • Picture Pill Count

    Open Access•Marcia M Holstad, Melinda Higgins et al.•AIDS and Behavior•2019

  • Multiple Dimensions of Stigma and Health Related Factors Among Young Black Men Who Have Sex with Men

    Open Access•K G Quinn, Kathleen Quinn et al.•AIDS and Behavior•2016

  • Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda

    Open Access•Peter Olds, Peter K Olds et al.•AIDS and Behavior•2014

  • A Randomized Controlled Trial Examining the Efficacy of Motivational Counseling with Observed Therapy for Antiretroviral Therapy Adherence

    Open Access•Kathy Goggin, Mary M Gerkovich et al.•AIDS and Behavior•2013

  • Mechanism of Change in Cognitive Behavioral Therapy for Body Image and Self-Care on ART Adherence Among Sexual Minority Men Living with HIV

    Open Access•Kalina M Lamb, Kelsey A Nogg et al.•AIDS and Behavior•2018

  • Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa

    Open Access•Denise Evans, Rebecca Berhanu et al.•AIDS and Behavior•2016

  • Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men

    Open Access•Susan Buchbinder, Aaron J Siegler et al.•AIDS and Behavior•2022

  • Gender Moderates Results of a Randomized Clinical Trial for the Khanya Intervention for Substance Use and ART Adherence in HIV Care in South Africa

    Open Access•Jennifer M Belus, John A Joska et al.•AIDS and Behavior•2022

  • Barriers to Medication Adherence in Behaviorally and Perinatally Infected Youth Living with HIV

    Open Access•Karen MacDonell, Sylvie Naar‐king et al.•AIDS and Behavior•2012

  • Cognitive Performance, as well as Depression, Alcohol Use, and Gender, predict Anti-Retroviral Therapy Adherence in a South African Cohort of People with HIV and Comorbid Major Depressive Disorder

    Open Access•Anna J Dreyer, Sam Nightingale et al.•AIDS and Behavior•2023

  • If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan

    Open Access•Alissa Davis, Lyailya Sarsembayeva et al.•AIDS and Behavior•2019

  • Mental Health, Self-Care, and Engagement in Care among Black Women Living with HIV

    Jordan Patrick, Sannisha K Dale•Ethnicity & Disease•2023

  • Pesky metrics

    Open Access•Rebecca Hodes, Lucie D Cluver et al.•Critical Public Health•2018

  • Syndemic indicators predict poor medication adherence and increased healthcare utilization for urban HIV-positive men who have sex with men

    David W Pantalone, Sarah E Valentine et al.•Journal of Gay & Lesbian Mental…•2017

  • Suubi+Adherence-Round 2

    Open Access•Fred M Ssewamala, Ozge Sensoy Bahar et al.•BMC Public Health•2021

  • A community health worker and mobile health app intervention to improve adherence to HIV medication among persons with HIV

    Open Access•Olivia R Wood, Rebecca Schnall et al.•BMC Public Health•2023

  • Protocol of the randomized control trial

    Open Access•Gabriella Flynn, Haomiao Jia et al.•BMC Public Health•2020

  • Study protocol to evaluate an integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH

    Open Access•Honghu Liu, Jie Shen et al.•BMC Public Health•2025

  • Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China

    Open Access•Xia Jin, Hongyi Wang et al.•BMC Public Health•2020

  • Factors associated with HIV positive sero-status among exposed infants attending care at health facilities

    Open Access•Methuselah Muhindo Kahungu, Julius Kiwanuka et al.•BMC Public Health•2018

  • Feasibility and Acceptability of Real-Time Antiretroviral Adherence Monitoring among Depressed Women Living with HIV in the Deep South of the US

    Open Access•Kristi L Stringer, Andres Azuero et al.•AIDS and Behavior•2018

  • A Pilot Randomized Control Trial of the Striving Towards EmPowerment and Medication Adherence (STEP-AD) Intervention for Black Women Living with HIV

    Open Access•Sannisha K Dale, Ian Wright et al.•AIDS and Behavior•2024

  • Correlation of Adherence by Pill Count, Self-report, Mems and Plasma Drug Levels to Treatment Response Among Women Receiving ARV Therapy for PMTCT in Kenya

    Open Access•Victor Mudhune, Roman Gvetadze et al.•AIDS and Behavior•2017

  • Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere

    Open Access•Jeffrey I Campbell, Nir Eyal et al.•AIDS and Behavior•2018

  • Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa

    Open Access•Melanie Abas, Primrose Nyamayaro et al.•AIDS and Behavior•2017

  • Feasibility, Performance, and Acceptability of the WisebagTM for Potential Monitoring of Daily Gel Applicator Use in Durban, South Africa

    Open Access•Ariane Van Der Straten, Elizabeth Montgomery et al.•AIDS and Behavior•2012

  • Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa

    Open Access•the Partners Mobile Adherence to PrEP Team, Timothy R Muwonge et al.•AIDS and Behavior•2018

  • Adherence to Oral HIV Pre-exposure Prophylaxis During Pregnancy and the Post-partum Period

    Open Access•Nokubonga Khoza, Nondumiso Khoza et al.•AIDS and Behavior•2025

  • Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda

    Open Access•Nicholas Musinguzi, Rain A Mocello et al.•AIDS and Behavior•2016

  • Supporting Adolescents to Adhere (Sata)

    Open Access•Sarah Maccarthy, Alexandra Mendoza-Graf et al.•Children and Youth Services Review•2019

  • A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa

    Open Access•Lene Søndergaard Andersen, Lena S Andersen et al.•Journal of Health Psychology•2018

  • The Technology Acceptance Model

    Open Access•Richard J Holden, Richard Holden et al.•Journal of Biomedical Informatics•2010

  • Efficacy of Antiretroviral Therapy Adherence Interventions

    K Rivet Amico, Jennifer J Harman et al.•JAIDS Journal of Acquired Immune…•2006

  • Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting

    Jessica H Oyugi, Jayne Byakika-Tusiime et al.•JAIDS Journal of Acquired Immune…•2004

  • Self-Report Measures of Antiretroviral Therapy Adherence

    Open Access•Jane M Simoni, Ann E Kurth et al.•AIDS and Behavior•2006

  • Non-adherence to highly active antiretroviral therapy predicts progression to Aids

    David R Bangsberg, Sharon Perry et al.•AIDS•2001

  • Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

    David R Bangsberg, FREDERICK HECHT et al.•AIDS•2000

  • Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

    Robert S Hogg, Katherine Heath et al.•AIDS•2002

  • User Acceptance of Information Technology

    Viswanath Venkatesh, Venkatesh Venkatesh et al.•MIS Quarterly•2003

  • Perceived Usefulness, Perceived Ease of Use, and User Acceptance of Information Technology

    Fred D Davis•MIS Quarterly•1989

  • Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating Haart in the MTCT-Plus Family Treatment Model

    Open Access•Jayne Byakika-Tusiime, Johanna T Crane et al.•AIDS and Behavior•2009

Unique citing works54
Citations per year3,86
Citation span2012 - 2026 (15)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 54
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae